Dr. Er Qi Wang is a Chairman & Chief Executive Officer at Jin Medical International Ltd., a Chairman & Chief Executive Officer at Changzhou Zhongjin Medical Equipment Co. Ltd. and a Member at China Wheelchair Association. Dr. Wang was previously employed as a Managing Director by Sangui Rehabilitation Equipment Shanghai Co. Ltd. He received his doctorate degree from Tohoku University.
Oliver St. Clair Franklin
Oliver St. Clair Franklin is currently Director at The Philadelphia Foundation and Dynamis Pharmaceuticals, Inc., and Independent Director at Jin Medical International Ltd. since 2023. Former positions include Chairman at Innovator ETFs Trust from 2007 to 2019, Vice Chairman at Electronic Ink, Inc. from 2006 to 2018, Director at Dynamis Therapeutics, Inc., Deputy City Representative for the City of Philadelphia (Pennsylvania), Founding Partner at Risa Investment Advisers LLC from 1997 to 2001, and Principal at International House of Philadelphia from 2001 to 2006. Education includes an undergraduate degree from Lincoln University (Pennsylvania), conferred in 1996.
Yan Ru Guo
Yan Ru Guo is currently an Independent Director at Jin Medical International Ltd. and Chief Accountant at Shineco, Inc. since 2014. Formerly, Ms. Guo was a Financial Manager at Beijing Mobile Interactive Co. Ltd. from 2008 to 2012. Education includes an undergraduate degree from Beihang University and a graduate degree from Dongbei University of Finance & Economics.
Jia Yuan Tong
Dr. Jia Yuan Tong is an Independent Director at Horizon Space Acquisition II Corp., an Independent Director at Jin Medical International Ltd. and an Independent Director at Papa Medical, Inc. He is on the Board of Directors at Horizon Space Acquisition II Corp., Xynomic Pharmaceuticals, Inc., Jin Medical International Ltd. and Papa Medical, Inc. Dr. Tong was previously employed as a Director & Partner by Korea Investment Partners Co., Ltd., an Executive Director, Chief Strategy Officer & EVP by Xynomic Pharmaceuticals Holdings, Inc., a Chief Executive Officer & Director by Bison Capital Acquisition Corp., a Partner by Bison Capital Holding Co., Ltd., a Partner by Delta Capital Investments (California), a Chief Financial Officer & Director by Tianyin Pharmaceutical Co., Inc., a Research Analyst by ROTH Capital Partners LLC, a Research Associate by Rodman & Renshaw LLC (Old), a Principal Investigator by The Marine Biological Laboratory, a Founder by Thorbay Holdings, and a Senior Research Fellow by University of California, Irvine. He received his undergraduate degree from Peking University and a doctorate degree from Stony Brook University.
提供，免责声明：天汇财经、Factset及其他信息供应商努力确保所提供信息的准确性和可靠性，但对于其正确性或可靠性则不予担保，且对于因不正确或疏漏所造成的任何损失或损坏概不负责(无论是有关民事过失、合同或其他方面)。